Zevra Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.80 -0.09 (-1.01%) USD | NASDAQ | Feb 20, 16:00

8.81 +0.01 (+0.11%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Verastem, Inc.	--
ADMA Biologics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--